跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,749 条关于
“OD-004”
全部
8,749
临床试验
3,248
药物
4,900
机构
9
资讯
592
5个月前
Odyssey Therapeutics Files for $232 Million Nasdaq IPO to Advance Autoimmune Disease Pipeline
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
去年
Pasithea's PAS-004 Outperforms FDA-Approved MEK Inhibitor in Preclinical IBD Study
去年
Astrocyte Pharmaceuticals Initiates Phase 2 Trial for First-in-Class Concussion Drug AST-004
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
去年
Cloudbreak Pharma's CBT-004 Achieves Primary Endpoint in Phase 2 Trial for Vascularized Pinguecula
去年
Armored anti-GPC3 JW-004 shows increased potency against HCC | BioWorld
2年前
Pasithea Therapeutics Announces FDA Acceptance of IND Application for PAS-004 in Advanced Cancer Patients
7个月前
Arctic Therapeutics Initiates Phase IIa Trial of Novel Acetylcholinesterase Inhibitor AT-004 for Acne Vulgaris
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
第 1 页,共 60 页
上一页
下一页